Journal article

Optimizing immunization in pediatric special risk groups

Nigel W Crawford, Julie E Bines, Jenny Royle, Jim P Buttery

Expert Review of Vaccines | TAYLOR & FRANCIS LTD | Published : 2011


Awarded by National Health and Medical Research Council (NHMRC) of Australia

Funding Acknowledgements

Nigel Crawford acknowledges support from a National Health and Medical Research Council (NHMRC) of Australia PhD Postgraduate Public Health Scholarship (437031) for his University of Melbourne thesis. The Murdoch Childrens Research Institute research fund has received honoraria for Nigel Crawford sitting on a Wyeth/Pfizer advisory board for pneumococcal vaccines and presentations at conferences and Nigel Crawford investigator-led research project support from CSL. Julie E Bines has investigator-led research on baseline epidemiology of intussusception and post-marketing surveillance of rotavirus vaccines supported by CSL and GSK and is Chair, Adverse Events Committee, Human Rotavirus Vaccine Group, Rotarix Trials, GSK Julie E Bines and Jim P Buttery have collaboration with BioFarma. Indonesia, for the development of the RV3 Rotavirus Vaccine. The Murdoch Childrens Research Institute research find has received honoraria for Jim P Buttery sitting on a data safety monitoring board for influenza vaccines (CSL) and GSK conference travel support. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.